Zacks' 7 Best Stocks for June, 2013
FREE Report for Zacks.com
Visitors Only

They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.

Today, you can see them free.

Close This Panel X

Are you a new Zacks Member or a visitor to Zacks.com?

Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Stocks on the Move 05/21/2013

Company Name Symbol %Change
SUMMER INFAN SUMR
9.64%
SCIENTIFIC L SCIL
8.00%
NATUS MEDICA BABY
5.76%
FEDERAL MOGU FDML
5.69%
NEW ORIENTAL EDU
5.44%

Hartford Upgraded to Neutral

by Zacks Equity Research

January 10, 2012 | Comments : 0 Recommended this article: (0)

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

We have upgraded our recommendation on Hartford Financial Services Group Inc. ( ( HIG - Analyst Report ) ) to Neutral from Underperform prompted by its initiatives to increase operational and financial efficiency. Nevertheless, we are a bit concerned about the lower 2011 earning guidance provided by the company on December 8, 2011.

Hartford has been selling off its non-core businesses in order to focus on its core businesses, thereby improving the operating performance in the long run. During the past three months, Hartford announced an agreement to sell its subsidiary Hartford Life Private Placement to Philadelphia Financial Group Inc. and completed the sale of Federal Trust Corporation, to CenterState Banks, Inc. (CSFL) and Trumbull Services LLC to ExlService Holdings, Inc. ( EXLS - Snapshot Report ) .

Additionally, Harford realizes the need to improve its financial efficiencies and risk management functions. For this, the company signed a multi-year agreement with Accenture Plc. ( ACN - Snapshot Report ) , whereby the latter will provide management and technology consultancy services along with finance and accounting business process outsourcing services.

On the flip side, management expects to report a decline in both AARP direct and agency businesses in 2011 earnings release, which will contribute to the expected decline in the year’s written premium. Management also expects the statutory surplus in Life operations to continue declining through 2012. This is also reflected in management’s expectation of a single-digit growth rate in 2012.

Additionally, the net investment income of Hartford varies significantly with changes in market conditions, thereby largely impacting the company’s net income. With the ongoing weak market conditions, the poor investment results are expected to continue in 2012 and beyond. Moreover, low interest rates since the mid-2010 coupled with the poor economic scenario have prompted management to declare that the achievement of the previously announced ROE target of 11% will be delayed beyond the earlier goal of 2012-end.

The Zacks Consensus Estimate for Hartford’s fourth-quarter 2011 earnings is currently 61 cents per share, down about 42% from the year-ago quarter. Moreover, for 2011, the Zacks Consensus Estimate stands at $1.86 per share, down about 44% from 2010.

Currently, Hartford carries a Zacks #3 Rank, implying a short-term ‘Hold’ rating.

Email Print Share Rate Pos Rate Neg

Read/Post Comments (0) | Recommended this article (0)

Please login to Zacks.com or register to post a comment.

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.